Download Files:
Products Details
Product Description
– Cap-dependent endonuclease-IN-7 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-7 Inhibits the synthesis of viral mRNA and eventually inhibits virus proliferation. Cap-dependent endonuclease-IN-7 has the potential for the research of viral infections (including influenza A, influenza B and influenza C) (extracted from patent WO2020177715A1, compound 5)[1]
Web ID
– HY-143750
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C36H28FN3O7S
References
– [1]Qingyun Ren, et al. Influenza virus replication inhibitor and use thereof. Patent WO2020177715A1.
CAS Number
– 2485715-97-5
Molecular Weight
– 665.69
SMILES
– O=C(OC)OCOC(C(C=C1)=O)=C(N1N([C@H](C2=CC=CC=C23)C4=CC=C(F)C=C4C5=C3SC(C6=CC=CC=C6)=C5)[C@@]7([H])N8CCOC7)C8=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Influenza Virus
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
